Dotimas, Kent John S.
HRN: 12-94-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
CEFUROXIME 750MG (VIAL)
09/13/2022
09/19/2022
IV
700mg
Q8hours
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes